期刊文献+

大肠良恶性肿瘤PTEN/MMAC1/TEP1肿瘤抑制基因的蛋白表达研究 被引量:10

STUDY OF SUPPRESSOR ONCOGENE PTEN/MMAC1/TEP1 PROTEIN EXPRESSION IN COLORECTAL ADENOMA AND CARCINOMA
下载PDF
导出
摘要 目的 :探讨 PTEN/ MMAC1/ TEP1与大肠癌的发生 ,发展的相关性。方法 :应用 S- P免疫组织化学方法检测 2 3例正常大肠粘膜、 2 8例大肠腺瘤和 75例大肠癌组织中 PTEN/ MMAC1/ TEP1蛋白的表达情况。结果 :2 3例正常大肠粘膜组织中PTEN蛋白表达阳性率为 91.3% (2 1/ 2 3) ,2 8例大肠腺瘤组织中 PTEN蛋白表达阳性率均为 89.3% (2 5 / 2 8) ,75例大肠癌组织中 PTEN蛋白表达阳性率为 6 8% (5 1/ 75 ) ,与正常大肠粘膜及大肠腺瘤差异有显著意义 (P <0 .0 1) ;有淋巴结转移的2 8例大肠癌阳性率为 43% (12 / 2 8) ,无淋巴结转移的 47例大肠癌阳性率为 83% (39/ 47) ,两者差异有显著意义 (P <0 .0 1) ;有远处器官转移的 2 3例大肠癌中阳性率为 43.5 % (10 / 2 3) ,无远处器官转移的 5 2例大肠癌阳性率为 78.8% (4 1/ 5 2 ) ,差异有显著意义 (P〈0 .0 1) ;6 0例大肠腺癌中蛋白表达阳性率为 81.2 % (4 9/ 6 0 ) ,15例粘液癌蛋白表达阳性率为 13.3% (2 / 15 ) ;两者之间有显著性差异 (P <0 .0 1) ;6 0例大肠腺癌中高 /中分化大肠腺癌 37例表达阳性率为 97.3% (36 / 37) ,低分化大肠腺癌 2 3例中表达阳性率为 5 6 .5 % (13/ 2 3) ,两者差异有显著意义 (P <0 .0 1)。结论 :PTEN/ MMAC1/ TEP1与大肠癌的发生。 Objective: To evaluate the relationship between PTEN/MMAC1/TEP1 expression and colorectal adenoma and carcinoma Methods:23 cases of human normal large intestinal mucosa,28 cases of colorectal adnoma and 75 cases colorectal carcinoma were investigated by immunohistochemical S P techinque through applieation of PTEN/MMAC1/TEP1 antibody Results:In the cases of nomal large intestinal mucosa and colorectal adnoma and carcinoma,the PTEN positive expression rates were 91 3%(21/23) and 89 3%(25/28) and 68%(52/75) respectively,and the differences were significant,P<0 01  The positive rates of those with or without lymph node metastasis were 43%(12/28) and 83%(39/47),and the differences were significiant,P<0 01 The positive rates of those with or without metastasis of distant organswere 43 5%(10/23) and 78 8%(41/52),P<0 01 The positive rates of colorectal adenocarcinoma and mucinous adenocarcina were 81 2%(49/60) and 13 3%(2/15),P<0 01;In the 60 cases of colorectal adenocarcinoma,the positive rates of well or moderately differentiated type and poorly differentiated type were 97 3%(36/37)and 56 5%(13/23),P<0 01 Conclusion:The results suggest that PTEN shows inhibitory effect on the occurence those and development ofcolorectalcarcinoma It may be of great value for clinical prognosis
出处 《大肠肛门病外科杂志》 2001年第2期9-13,共5页 Journal of Coloproctological Surgery
关键词 大肠癌 大肠腺癌 PTEN/MMAC1/TEP1 免疫组织化学 Colorectalcancer Colorectal adenoma PTEN/MMAC1/TEP1 Immunohistochemistry
  • 相关文献

参考文献4

二级参考文献4

  • 1姚开泰.抑瘤基因.细胞周期.DNA修复与肿瘤易感性[J].中国科学基金,1997,2:17-17.
  • 2纪小龙,诊断免疫组织化学,1997年,43页
  • 3姚开泰,中国科学基金,1997年,2期,17页
  • 4杨光霖,董聿明.胃肠道肿瘤研究新动向[J].中华病理学杂志,1997,26(3):131-133. 被引量:2

共引文献7

同被引文献85

  • 1周隽,吴强,杨枫.乳腺癌中PTEN表达及其临床病理意义[J].临床与实验病理学杂志,2003,19(2):162-164. 被引量:12
  • 2张亚厉 张振书 杨希山主编.大肠癌的基础与临床:第1版[M].上海:上海科学技术出版社,1999.164.
  • 3Li j, Yen C, Liaw D, et al. PTEN a putative protein tyrosine phosphatase gene mutated in human brain and prostate cancer.Science, 1997, 275 (5308): 1943-1947.
  • 4Taniyama K, Goodison S, Lto R, et al. PTEN expression is maintained in sporadic colorectal tumors. J Pathol, 2001, 194(3):341-348.
  • 5Sano T, Lin H, Chen X, et al. Differential expression of MMAC/PTEN in gliohlastoma multiforme: relationship to localization and prognosis. Cancer Res.1999, 59 (8): 1820-1824.
  • 6Levine A J, Perry ME, Chang A, et al. The 1993 walter Hubert lecture: the role of th 1353 tumor suppressor gene in tumorigenesis. Br J Cancer, 1994,69:409.
  • 7Monica H, David S, Bert V, et al. p53 mutation in human cancer. Science,1991,293:49.
  • 8Baker SJ, Fearon Er, Nigro MJ, et al. Chromsome 17 deletions and p53 gene mutations in colorectal carciranas. Science, 1989,244: 217.
  • 9Carson DA, Lois A. Cancer progression and p53. lancet, 1995,346:1009.
  • 10Baker SJ, Presinger AC, Jessup JM, et al. p53 gene nmtations occut in combination with 17p allelie deletions as late event in colorectal tumorigenesis.Cancer Rgs, 1990,50:7717.

引证文献10

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部